A STAT2-gated reservoir redirects interferon signaling during inflammation

Cells are constantly listening to their surroundings, translating chemical signals from the outside world into instructions for the nucleus, where the cell's genetic library resides. One of the primary ways they do this is through a communication line known as the JAK-STAT pathway. Imagine a relay race where a signal hits a receptor on the cell surface, activating a chain of proteins that rush to the nucleus to turn specific genes on or off. For decades, scientists viewed this process as a straightforward, linear line: a signal arrives, the proteins activate, and the cell responds. However, this simple model struggles to explain how a single signal, specifically one called type I interferon, can produce two completely opposite results. In some situations, this signal helps the body fight off viruses; in others, it can worsen bacterial infections or cause severe tissue damage during systemic inflammation. The question that has long puzzled researchers is how the same message can be interpreted so differently depending on the context.

A team of researchers at the Cleveland Clinic and Case Western Reserve University has now uncovered the mechanism behind this flexibility. They discovered that the cell does not simply react to interferon in a linear fashion. Instead, the cell maintains a pre-assembled storage unit, or reservoir, of two specific proteins, STAT1 and STAT2, that acts as a gatekeeper. This reservoir holds the potential for a strong immune response in a dormant state, waiting for a second signal to decide whether to release it for antiviral defense or to redirect it for antibacterial warfare.

The researchers began by observing how immune cells, specifically macrophages, responded to different threats. When these cells were exposed to a virus-like trigger, they produced a standard set of genes designed to fight viruses. However, when the same cells were exposed to a bacterial trigger, such as lipopolysaccharide, the response changed dramatically. The cells still produced interferon, but they also activated a distinct set of genes responsible for killing bacteria and generating reactive oxygen species. Crucially, the researchers found that the interferon signal alone was not enough to trigger this bacterial-fighting program; it required the presence of inflammation. This suggested that the inflammatory environment was rewiring the interferon signal, but the physical mechanism for how this happened remained a mystery.

To solve this, the team turned to high-resolution imaging and structural biology. They managed to capture a detailed three-dimensional structure of the STAT1 and STAT2 proteins locked together in a complex. What they saw was not a simple, symmetrical pair, but an asymmetric scaffold. In this structure, the two proteins fit together in a specific way that creates a stable holding pattern. This arrangement allows the cell to keep STAT1, the protein responsible for driving the inflammatory response, ready and waiting, but held in check by STAT2. The researchers identified a specific region on the STAT2 protein, a flexible linker segment unique to it, that is essential for maintaining this stable, pre-assembled state. Without this specific linker, the proteins could not form the correct reservoir, and the cell lost its ability to properly activate STAT1.

The study revealed that this reservoir operates on a "catch, hold, and release" cycle. When interferon first arrives, it activates the pre-assembled STAT1-STAT2 pair. Under normal conditions, a third protein called IRF9 joins this pair to form a complex that fights viruses. However, the cell typically has far more STAT1 and STAT2 than it does IRF9. This shortage means that many of the activated STAT1-STAT2 pairs cannot find an IRF9 partner and remain stuck in the reservoir, held in a stable state. They are not destroyed or discarded; they are simply waiting.

The "release" step occurs when the cell encounters a second signal, specifically inflammation. The researchers found that inflammatory signals activate enzymes called TBK1 and IKKε, which attach a chemical tag to a specific spot on the STAT2 protein. This tag acts as a molecular switch. When it is attached, it destabilizes the reservoir, causing the STAT1 and STAT2 proteins to separate. Once freed from the reservoir, the STAT1 proteins are able to pair with each other to form homodimers. These STAT1 homodimers then rush to the nucleus and turn on the genes responsible for fighting bacteria and managing inflammation.

To prove that this mechanism is vital for survival, the researchers created mice with genetic modifications that disrupted this cycle. In one group, they prevented the chemical tag from being attached, effectively locking the reservoir in the "hold" position. These mice were better at surviving the initial shock of severe bacterial infection because they did not produce an overwhelming inflammatory response too early. However, they eventually succumbed because they could not mobilize the necessary defenses to clear the bacteria. In another group, they made the reservoir unstable, causing it to fall apart prematurely. These mice failed to activate the immune response at all, leaving them vulnerable to the infection from the start. These findings demonstrate that the reservoir must be dynamic; it needs to be stable enough to hold the signal but flexible enough to release it at the right moment.

The team also tested whether they could manipulate this timing with a drug. By using a compound to temporarily block the enzyme that triggers the release, they were able to stabilize the reservoir. When given before the infection, this treatment protected the mice from the initial inflammatory damage. However, if the drug was given too late, after the infection had already taken hold, it prevented the mice from mounting the necessary defense, leading to worse outcomes. This confirmed that the timing of the reservoir's release is just as important as the release itself.

This work redefines our understanding of how cells process immune signals. It shows that the JAK-STAT pathway is not a simple on-off switch but a sophisticated system with a built-in memory and a gating mechanism. The cell uses the physical structure of its proteins and the relative abundance of its components to store potential energy, releasing it only when the specific context of inflammation demands it. This discovery explains how the same interferon signal can be both a protector and a destroyer, depending on when and how the reservoir is opened. It also suggests that future treatments for inflammatory diseases might not need to block the entire immune system, but could instead focus on the precise timing of these molecular switches to restore balance.